Clinico-laboratory profile of dengue patients in a tertiary hospital of Eastern India

Malati Murmu, Lagendra Kumar Singh, Suchita Sambhaji Kamble, Laxmikanta Dash, Karun Mahesh K. P., Joyal J. Kandathil


Background: Dengue is the most rapidly spreading mosquito-borne viral disease of mankind. According to WHO, about 50-100 million new dengue infections are estimated to occur annually in more than 100 endemic countries.So, the present study has been done to analyzed varied clinical and laboratory profile of confirm dengue cases.

Methods: Cross-sectional observational study was undertaken among 106 adult Ig M Ab positive cases admitted during October 2015 to September 2017. All patients were evaluated clinically and subjected for relevant laboratory investigations.

Results: In our study male and female ratio was 20.2:1. Most common symptom was fever (95.3%) and least common was jaundice. Second most symptom was headache (70.8%). Myalgia was present in 49.1% of cases. 54.7% had nausea/vomiting. Hypotension was noticed in 33% of cases whereas encephalopathy and melaena was found in 6.6% and 2.83% respectively. Leucopenia was present in 57.5% and thrombocytopenia in 50.9% of cases.

Conclusions: Younger male were commonly affected with dengue fever and promptly responded to conservative therapy due to early confirmation of diagnosis. Mortality was only 1.8% cases, may be due to delay in seeking medical attention.


Aedes aegypti, Dengue fever, Dengue hemorrhagic fever (DHF), Flavivirus, Laboratory profile

Full Text:



World Health Organization. Special Programme for Research, Training in Tropical Diseases, World Health Organization. Department of Control of Neglected Tropical Diseases, World Health Organization. Epidemic, Pandemic Alert. Dengue: guidelines for diagnosis, treatment, prevention and control. World Health Organization; 2009.

Deshwal R, Qureshi MI, Singh R. Clinical and laboratory profile of dengue fever. J Assoc Physicians India. 2015;63(12):30-2.

Nisalak A, Endy TP, Nimmannitya S, Kalayanarooj S, Scott RM, Burke DS, et al. Serotype-specific dengue virus circulation and dengue disease in Bangkok, Thailand from 1973 to 1999. Am J Trop Med Hyg. 2003;68(2):191-202.

Chen R, Vasilakis N. Dengue-quo tu et quo vadis?. Viruses. 2011;3(9):1562-608.

Centers for Disease Control and Prevention. Imported dengue-United States, 1997 and 1998. MMWR. Morbidity and mortality weekly report. 2000;49(12):248-53.

Engelthaler DM, Fink TM, Levy CE, Leslie MJ. The reemergence of Aedes aegypti in Arizona. Emerg Infect Dis. 1997;3(2):241-2.

Kyle JL, Harris E. Global spread and persistence of dengue. Annu Rev Microbiol. 2008;62:71-92.

Restrepo BN, Beatty ME, Goez Y, Ramirez RE, Letson GW, Diaz FJ, et al. Frequency and clinical manifestations of dengue in urban Medellin, Colombia. Journal of tropical medicine. 2014;2014.

Khan MY, Venkateshwarlu C, Sandeep N, Krishna AH. A study of clinical and laboratory profile of dengue fever in a tertiary care hospital, Nizamabad, Telangana State, India. Int J Cont Med Res. 2016;3(8):2383-387.

Kumar CM, Vyas KSK, Krishna YS. Clinical profile of dengue fever with severe thrombocytopenia and its complications: a retrospective study at a tertiary care hospital in South India. Int J Res Med Sci. 2017;5(5):1751-5.

World Health Organization. Comprehensive guidelines for prevention and control of dengue and dengue hemorrhagic fever. New Delhi: WHO, SEARO;2011.

Borawake K, Prayag P, Wagh A, Dole S. Dengue encephalitis. Ind J Crit care Med. 2011;15(3):190-193.

Withana M, Rodrigo C, Chang T, Karunanayake P, Rajapakse S. Dengue fever presenting with acute cerebellitis: a case report. BMC research notes. 2014;7:125.

Soares CN, Faria LC, Peralta JM, De Freitas MR, Puccioni-Sohler M. Dengue infection: neurological manifestations and cerebrospinal fluid (CSF) analysis. J Neurolog Sci. 2006;249(1):19-24.

Hira HS, Kaur A, Shukla A. Acute neuromuscular weakness associated with dengue infection. J Neurosci Rural Prac. 2012;3(1):36.